NEDEN BİBERİYE YETİŞTİRMELİYİZ? BİLİMİN IŞIĞINDA SUSUZ TARIM BİTKİLERİNDEN; BİBERİYE


BİBERİYE (Rosmarinus officinalis)

İçeriğindeki bazı önemli etken maddeler: Rozmarinik asit, karnosol, karnosik asit, ursolik asit, oleanolik asit.


Klinik deney sonuçlarına göre biberiyenin sağlığa faydaları: 






















KLİNİK DENEY BULGULARINA GÖRE BİBERİYENİN SAÇ BAKIMINA FAYDALARI:

Saç köklerini besleyerek dökülmeyi engeller ve yeniden saç oluşumunu destekler. Kepeklenmeyi önler. Erkek tipi kelliğin önlenmesine yardımcı olur ve hem kadınlarda hem de erkeklerde görülebilen saç kıran tedavisini destekler.[1] [2] [3] [4]


KLİNİK DENEY SONUÇLARINA GÖRE BİBERİYENİN SAĞLIĞA FAYDALARI:


Dizlerde osteoartrit (kireçlenme);

  • Antienflamatuvar (ödemi azaltan)[5] [6] ve analjezik (ağrı kesici)[7] [8] [9] [10] [11] özelliği sayesinde romatizma, kas ve eklem ağrısını yatıştırmaya yardımcı olur.
  • İbn-i Sina, Hipokrat ve Galen, biberiye yapraklarını zeytinyağında maserasyon yaparak eklem ağrılarını ve yaraları iyileştirmişlerdir.[12]

Burun polipleri;

  • Burun içi poliplerin burundan geçen havanın akışını engelleyerek burun tıkanıklığına sebep olması.[13] [14]

Gastrointestinal sistem hastalıkları;

  • Yemek borusu, mide, ince bağırsaklar, kalın bağırsaklar, anal kanal, karaciğer, safra kesesi, safra yolları, pankreas organlarını ilgilendiren hastalıkların tedavisi.
  • Gaz giderici olarak kullanılabilir[15] [16] [17] ve hazımsızlığa iyi gelir.[18] [19] [20]
  • Laboratuvar fareleri üzerinde yapılan deneyler, biberiyeden elde edilen “karsonik asit” ve “ester türevleri”nin gastrik (mide içi) lezyonlarını önlemede etkili olduğunu göstermiştir.[21]

Kalp ve damar hastalıkları;[22] [23] [24]

  • Kan dolaşımını düzenler ve bu sayede selülit oluşumunu da engeller.[25]

Metabolik sendrom X;[26] [27] [28] [29] [30] [31] [32] [33]

  • Gövdesel obezite, insülin rezistansı, kan yağları bozukluğu, hipertansiyon ile karakterize ve kardiyovasküler risk faktörleri oluşturan bir modern zamanlar hastalığıdır.

Sarkopeni;[34] [35] [36]

  • Yaşla birlikte kas kütlesi ve gücünde azalması.

İyi huylu prostat büyümesi;

  • İçeride kalan idrar nedeniyle enfeksiyonlara ve böbrek fonksiyonlarında bozulmaya yol açan bir hastalıktır. Biberiye, idrar söktürücü ve spazm engelleyici olarak kullanılabilir. [37] [38] [39]

Kanser çeşitleri;

  • Biberiyenin anti-enflamatuvar[40] [41] ve anti-tümör[42] [43] [44] [45] [46] [47] [48] özellikleri, bu bitkiyi kanser tedavisi için en umut vaat eden adaylardan biri yapmaktadır.[49] [50] [51]
  • Biberiyede, “polifenol” adı verilen, kanseri önleme etkisine sahip ve güçlü antioksidan karakter gösteren kimyasal yapılar bulunmaktadır.[52]
  • Biberiyenin kanser önleyici özellikleri üstünde yapılan klinik deneyler, özellikle melanoma,[53] kolon kanseri,[54] meme kanseri,[55] yumurtalık kanseri,[56] prostat kanseri,[57] [58] karaciğer kanseri[59] [60] ve lösemi[61] (kan kanseri) tedavisinde etkin rol oynayabileceğini göstermiştir.
  • Özellikle, laboratuvar fareleri üzerinde yapılan çalışmalar biberiyeden elde edilen “karnosol”un ve “karnosik asit”in meme kanseri ve kolon kanseri tümörleri üzerinde sitotoksik yani hücre yapısını bozucu etkiye sahip olduğunu göstermiştir. [62]   [63] Biberiyeden elde edilen karnosik asitin doğru miktarda ve düzeni olarak kullanıldığında dirençli tümör hücrelerinin öldüğü görülmüştür.

Covid19[64] [65] ve SARS[66] [67] benzeri bulaşıcı hastalıklar;

  • Antibakteriyel[68] [69] ve antimikrobiyal[70] özellik taşır.
  • Soğuk algınlığını ve öksürüğü önlemek ve tedavi etmek için kullanılır.[71] [72]
  • Balgam söktürücü olarak kullanılabilir.[73] [74] [75]

Merkezi sinir sistemi hastalıkları (örneğin; epilepsi, Alzheimer, Parkinson, demans, migren, MS, inme, depresyon vb.);[76] [77] [78] [79] [80] [81] [82] [83] [84]

Diyabet (Diabetes mellitus);[85]

  • Diyabet önleyici özelliği sayesinde kandaki glikoz seviyesini düşürdüğü fareler üzerinde yapılan klinik deneyler ile kanıtlanmıştır.[86] [87] Diyabet, dünyadaki en yaygın metabolik bozukluklardan biridir. Diyabet için insülin ve ağızdan verilen hipoglisemi ilaçları için kullanılsa da bunlar hastalığı tedavi etmez ve önemli yan etkileri vardır.[88]

Renal kolikte idrar söktürücü ve spazm engelleyici olarak kullanılabilir.[89] [90] [91]

Küçük yara ev döküntüleri dezenfekte ve tedavi etmeye yardımcı olur.[92] [93] [94]

Baş ağrısını önleyici ve yatıştırıcı etkisi vardır.[95] [96] [97]


KLİNİK DENEYLERE GÖRE BİBERİYENİN GIDA ALANINDAKİ FAYDALARI:

Biberiye, mutfakta yemeğe lezzet katmak ve gıdanın raf ömrünü uzatmak için yaygın olarak kullanılan bir bitkidir. Avrupa Birliği, antioksidan [98], antimikrobiyal [99] ve antibakteryal [100] etkisi bulunan biberiye ekstraktının doğal, güvenli ve etkili gıda koruyucu olarak kullanılabileceğini kabul etmektedir. [101]

LÜTFEN DİKKAT:

Biberiye uçucu yağının içeriğinde %5–21 oranında kafur bulunmaktadır [102] ve bu nedenle ağızdan alınırken mutlaka uzman hekime danışılmalıdır. Kafur, toksik bir maddedir ve epilepsi benzeri nöbetlere, huzursuzluğa, kafa karışıklığına ve mide rahatsızlığına sebep olabilir [103]

[1] Dhariwala, M.J.; Ravikumar, P. “An overview of herbal alternatives in androgenetic alopecia.” J. Cosmet. Dermatol. 18 (2019): 966–975.

[2] González-Minero, Francisco José, Luis Bravo-Díaz, and Antonio Ayala-Gómez. "Rosmarinus officinalis L.(Rosemary): An ancient plant with uses in personal healthcare and cosmetics." Cosmetics 7, no. 4 (2020): 77.
[3] Hashem, Mona M., Dalia Attia, Yomna A. Hashem, Moataz S. Hendy, Safa AbdelBasset, Farah Adel, and Maha M. Salama. "Rosemary and neem: an insight into their combined anti-dandruff and anti-hair loss efficacy." Scientific Reports 14, no. 1 (2024): 7780.
[4] Yehia, Rania M., Caroline Lamie, and Dalia A. Attia. "Microsponges-mediated targeted topical delivery of rosemary oil for hair growth promotion: optimization and in-vivo studies." Pharmaceutical Development and Technology 29, no. 6 (2024): 604-617.

[5] Yu, Mi-Hee et al. “Suppression of LPS-induced inflammatory activities by Rosmarinus officinalis L.” Food chemistry vol. 136,2 (2013): 1047-54
[6] Takaki, I et al. “Anti-inflammatory and antinociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models.” Journal of medicinal food vol. 11,4 (2008): 741-6.
[7] Begum A, Sandhya S, Shaffath Ali S, Vinod KR, Reddy S, Banji D. “An in-depth review on the medicinal flora Rosmarinus officinalis (Lamiaceae).” Acta Sci. Pol. Technol. Aliment. 12,1, (2013): 61–73.
[8] al-Sereiti, M R et al. “Pharmacology of rosemary (Rosmarinus officinalis Linn.) and its therapeutic potentials.” Indian journal of experimental biology vol. 37,2 (1999): 124-30.
[9] Aumeeruddy-Elalfi Z, Gurib-Fakim A, Mahomoodally F. “Antimicrobial, antibiotic potentiating activity and phytochemical profile of essential oils from exotic and endemic medicinal plants of Mauritius.” Ind. Crops Prod. 71, (2015): 197–204.
[10] Zhang, Yi et al. “New terpenoid glycosides obtained from Rosmarinus officinalis L. aerial parts.” Fitoterapia vol. 99 (2014): 78-85. 
[11] Calvo, M I et al. “Pharmaceutical ethnobotany in the Riverside of Navarra (Iberian Peninsula).” Journal of ethnopharmacology vol. 135,1 (2011): 22-33. 
[12] Font-Quer, P. Plantas Medicinales. El Dioscórides Renovado; Península: Barcelona, Spain, 2007; p. 562.
[13] Goronfolah, L. T., P. Ferrie, M. Schmuck, S. Waserman, J. Denburg, L. Kott, P. Keith, L. Crawford, and R. Fletcher. "A double-blind, placebo-controlled, randomized, crossover trial of a mint tea high in rosmarinic acid in adults with nasal polyposis." Journal of Allergy and Clinical Immunology 123, no. 2 (2009): 202-S202.
[14] Meletis, Chris D., and Nieske Zabriskie. "To Sleep, Perchance to Breathe: Sleep Apnea, Snoring, and Sleep-Disordered Breathing." Alternative & Complementary Therapies 12, no. 3 (2006): 113-120.
[15] Heinrich M, Barnes J, Gibbons S, Williamson E. Fundamentals of Pharmacognosy and Phytotherapy (2nd Edition). Elsevier Health Sciences, Edinburgh, UK.
[16] Begum, Asia et al. (2013): 61-73.
[17] Evans WC. Trease and Evans’ Pharmacognosy (16th Edition). Elsevier Health Sciences, Edinburgh, UK (2009).
[18] Begum, Asia et al. (2013): 61-73.
[19] al-Sereiti, M R et al. (1999): 124-30.
[20] Ulbricht, Catherine et al. “An evidence-based systematic review of rosemary (Rosmarinus officinalis) by the Natural Standard Research Collaboration.” Journal of dietary supplements vol. 7,4 (2010): 351-413. 
[21] Theoduloz, Cristina et al. “Gastroprotective effect and cytotoxicity of carnosic acid derivatives.” Planta medica vol. 77,9 (2011): 882-7.

[22] Begum, Asia et al. (2013): 61-73.
[23] al-Sereiti, M R et al. (1999): 124-30.
[24] Ulbricht, Catherine et al., (2010): 351-413. 
[25] Yimam, M.; Lee, Y.; Giao, P.; Hong, M.; Brownell, L.; Jia, Q. A Standardized Composition Comprised of Extracts from Rosmarinus officinalis, Annona squamosa and Zanthoxylum clava-herculis for Cellulite. Pharmacog. Res. 2017, 9, 319–324.
[26] Hassani, Faezeh Vahdati, Kobra Shirani, and Hossein Hosseinzadeh. "Rosemary (Rosmarinus officinalis) as a potential therapeutic plant in metabolic syndrome: a review." Naunyn-Schmiedeberg's archives of pharmacology 389 (2016): 931-949.
[27] Zhao, Yantao, Rashin Sedighi, Pei Wang, Huadong Chen, Yingdong Zhu, and Shengmin Sang. "Carnosic acid as a major bioactive component in rosemary extract ameliorates high-fat-diet-induced obesity and metabolic syndrome in mice." Journal of agricultural and food chemistry 63, no. 19 (2015): 4843-4852.
[28] Sedighi, Rashin, Yantao Zhao, Aaron Yerke, and Shengmin Sang. "Preventive and protective properties of rosemary (Rosmarinus officinalis L.) in obesity and diabetes mellitus of metabolic disorders: a brief review." Current Opinion in Food Science 2 (2015): 58-70.
[29] Sedighi, Rashin. "Carnosic Acid Enriched Rosemary Extract Prevents Obesity and Metabolic Syndrome in High-Fat Diet-Fed Mice." PhD diss., North Carolina Agricultural and Technical State University, 2014.
[30] Tu, Zheng, Tijuana Moss-Pierce, Paul Ford, and T. Alan Jiang. "Rosemary (Rosmarinus officinalis L.) extract regulates glucose and lipid metabolism by activating AMPK and PPAR pathways in HepG2 cells." Journal of agricultural and food chemistry 61, no. 11 (2013): 2803-2810.
[31] Zych, Maria, Ilona Kaczmarczyk-Sedlak, Weronika Wojnar, and Joanna Folwarczna. "Effect of rosmarinic acid on the serum parameters of glucose and lipid metabolism and oxidative stress in estrogen-deficient rats." Nutrients 11, no. 2 (2019): 267.
[32] Filip, Vlavcheski. "Inhibition of Free fatty acid-Induced Insulin Resistance by Rosemary Extract: Investigation of the Mechanisms Involved." (2018).
[33] Naimi, Madina, Filip Vlavcheski, Hesham Shamshoum, and Evangelia Tsiani. "Rosemary extract as a potential anti-hyperglycemic agent: Current evidence and future perspectives." Nutrients 9, no. 9 (2017): 968.
[34] Lee, Jun Ho, Jung Yoon Jang, Young Hoon Kwon, Seung Ho Lee, Cheol Park, Yung Hyun Choi, and Nam Deuk Kim. "Effects of Rosemary Extract on C2C12 Myoblast Differentiation and 5-Aminoimidazole-4-carboxamide Ribonucleoside (AICAR)-Induced Muscle Cell Atrophy." Applied Sciences 13, no. 2 (2023): 986.
[35] Morel, Sylvie, Gérald Hugon, Manon Vitou, Marie Védère, Françoise Fons, Sylvie Rapior, Nathalie Saint, and Gilles Carnac. "A bioassay-guided fractionation of rosemary leaf extract identifies carnosol as a major hypertrophy inducer in human skeletal muscle cells." Nutrients 13, no. 12 (2021): 4190.
[36] Sabarathinam, Sarvesh, Sanjana Satheesh, and Arun Raja. "Plant-based medicines in the treatment of cardiometabolic disorders: a special view on sarcopenic obesity." Obesity Medicine 41 (2023): 100497.
[37] Begum, Asia et al. (2013): 61-73.
[38] al-Sereiti, M R et al. (1999): 124-30.
[39] Ulbricht, Catherine et al., (2010): 351-413.
[40] Yu, Mi-Hee et al. (2013): 1047-54.
[41] Takaki, I et al. (2008): 741-6. 
[42] Tai, Joseph et al. “Antiproliferation effect of Rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro.” Phytomedicine : international journal of phytotherapy and phytopharmacology vol. 19,5 (2012): 436-43. 
[43] Huang, M T et al. “Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.” Cancer research vol. 54,3 (1994): 701-8.
[44] Dörrie, J et al. “Carnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cells.” Cancer letters vol. 170,1 (2001): 33-9. 
[45] Tsai, Chia-Wen et al. “Carnosic acid induces the NAD(P)H: quinone oxidoreductase 1 expression in rat clone 9 cells through the p38/nuclear factor erythroid-2 related factor 2 pathway.” The Journal of nutrition vol. 141,12 (2011): 2119-25. 
[46] Barni, M V et al. “Carnosic acid inhibits the proliferation and migration capacity of human colorectal cancer cells.” Oncology reports vol. 27,4 (2012): 1041-8.
[47] Cheung, Susan, and Joseph Tai. “Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis.” Oncology reports vol. 17,6 (2007): 1525-31.
[48] Yesil-Celiktas, Ozlem et al. “Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines.” Plant foods for human nutrition (Dordrecht, Netherlands) vol. 65,2 (2010): 158-63. 
[49] Petiwala, Sakina M., and Jeremy J. Johnson. "Diterpenes from rosemary (Rosmarinus officinalis): Defining their potential for anti-cancer activity." Cancer letters 367, no. 2 (2015): 93-102.
[50] Ngo, Suong NT, Desmond B. Williams, and Richard J. Head. "Rosemary and cancer prevention: preclinical perspectives." Critical reviews in food science and nutrition 51, no. 10 (2011): 946-954.
[51] González-Vallinas, Margarita, Guillermo Reglero, and Ana Ramírez de Molina. "Rosemary (Rosmarinus officinalis L.) extract as a potential complementary agent in anticancer therapy." Nutrition and cancer 67, no. 8 (2015): 1223-1231.
[52] Moore, Jessy, Michael Yousef, and Evangelia Tsiani. "Anticancer effects of rosemary (Rosmarinus officinalis L.) extract and rosemary extract polyphenols." Nutrients 8, no. 11 (2016): 731.
[53] Cattaneo, Lucia, Rosella Cicconi, Giuseppina Mignogna, Alessandra Giorgi, Maurizio Mattei, Giulia Graziani, Rosalia Ferracane et al. "Anti-proliferative effect of Rosmarinus officinalis L. extract on human melanoma A375 cells." PloS one 10, no. 7 (2015): e0132439.
[54] Borrás-Linares, Isabel, Almudena Pérez-Sánchez, Jesús Lozano-Sánchez, Enrique Barrajon-Catalan, David Arráez-Román, Alejandro Cifuentes, Vicente Micol, and Antonio Segura Carretero. "A bioguided identification of the active compounds that contribute to the antiproliferative/cytotoxic effects of rosemary extract on colon cancer cells." Food and Chemical Toxicology 80 (2015): 215-222.
[55] Jaglanian, Alina, and Evangelia Tsiani. "Rosemary extract inhibits proliferation, survival, Akt, and mTOR signaling in triple-negative breast cancer cells." International journal of molecular sciences 21, no. 3 (2020): 810.
[56] Tai, Joseph, Susan Cheung, Matthew Wu, and David Hasman. "Antiproliferation effect of Rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro." Phytomedicine 19, no. 5 (2012): 436-443.
[57] Petiwala, Sakina M., Angela G. Puthenveetil, and Jeremy J. Johnson. "Polyphenols from the Mediterranean herb rosemary (Rosmarinus officinalis) for prostate cancer." Frontiers in pharmacology 4 (2013): 29.
[58] Jaglanian, Alina, Deborah Termini, and Evangelia Tsiani. "Rosemary (Rosmarinus officinalis L.) extract inhibits prostate cancer cell proliferation and survival by targeting Akt and mTOR." Biomedicine & Pharmacotherapy 131 (2020): 110717
[59] Offord, Elizabeth A., Katherine Macé, Ornella Avanti, and Andrea MA Pfeifer. "Mechanisms involved in the chemoprotective effects of rosemary extract studied in human liver and bronchial cells." Cancer Letters 114, no. 1-2 (1997): 275-281.
[60] Rašković, Aleksandar, Isidora Milanović, Nebojša Pavlović, Tatjana Ćebović, Saša Vukmirović, and Momir Mikov. "Antioxidant activity of rosemary (Rosmarinus officinalis L.) essential oil and its hepatoprotective potential." BMC complementary and alternative medicine 14 (2014): 1-9.
[61] Sharabani, Hagar, Eugene Izumchenko, Qing Wang, Rita Kreinin, Michael Steiner, Zeev Barvish, Michael Kafka et al. "Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia." International Journal of Cancer 118, no. 12 (2006): 3012-3021.
[62] Dörrie, J et al. “Carnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cells.” Cancer letters vol. 170,1 (2001): 33-9. 
[63] Bai, Naisheng et al. “Flavonoids and phenolic compounds from Rosmarinus officinalis.” Journal of agricultural and food chemistry vol. 58,9 (2010): 5363-7
[64] Shiravi, Amirabbas, Aliakbar Akbari, Zahra Mohammadi, Mohammad-Sadegh Khalilian, Alireza Zeinalian, and Mehrdad Zeinalian. "Rosemary and its protective potencies against COVID-19 and other cytokine storm associated infections: A molecular review." Mediterranean journal of nutrition and metabolism 14, no. 4 (2021): 401-416.
[65] Satoh, Takumi, Dorit Trudler, Chang-Ki Oh, and Stuart A. Lipton. "Potential therapeutic use of the rosemary diterpene carnosic acid for Alzheimer’s disease, Parkinson’s disease, and long-COVID through NRF2 activation to counteract the NLRP3 inflammasome." Antioxidants 11, no. 1 (2022): 124.
[66] Silva, E. F., P. F. F. Silva, and T. Rico. Anti-SARS-CoV effect of rosemary (Rosmarinus officinalis): A blind docking strategy. 2020.
[67] Yao, Yuanhang, Uyory Choe, Yanfang Li, Zhihao Liu, Melody Zeng, Thomas TY Wang, Jianghao Sun et al. "Chemical Composition of Rosemary (Rosmarinus officinalis L.) Extract and Its Inhibitory Effects on SARS-CoV-2 Spike Protein–ACE2 Interaction and ACE2 Activity and Free Radical Scavenging Capacities." Journal of Agricultural and Food Chemistry 71, no. 48 (2023): 18735-18745.
[68] Bozin, Biljana et al. “Antimicrobial and antioxidant properties of rosemary and sage (Rosmarinus officinalis L. and Salvia officinalis L., Lamiaceae) essential oils.” Journal of agricultural and food chemistry vol. 55,19 (2007): 7879-85. 
[69] Sienkiewicz, Monika, Monika Łysakowska, Marta Pastuszka, Wojciech Bienias, and Edward Kowalczyk. "The potential of use basil and rosemary essential oils as effective antibacterial agents." Molecules 18, no. 8 (2013): 9334-9351.
[70] Nieto, Gema, Gaspar Ros, and Julián Castillo. "Antioxidant and antimicrobial properties of rosemary (Rosmarinus officinalis, L.): A review." Medicines 5, no. 3 (2018): 98.
[71] Zhang, Yi et al. (2014): 78-85. 
[72] Calvo, M I et al. “Pharmaceutical ethnobotany in the Riverside of Navarra (Iberian Peninsula).” Journal of ethnopharmacology vol. 135,1 (2011): 22-33. 
[73] Begum, Asia et al. (2013): 61-73.
[74] al-Sereiti, M R et al. (1999): 124-30.
[75] Ulbricht, Catherine et al., (2010): 351-413. 
[76] Satoh, Takumi, Dorit Trudler, Chang-Ki Oh, and Stuart A. Lipton. "Potential therapeutic use of the rosemary diterpene carnosic acid for Alzheimer’s disease, Parkinson’s disease, and long-COVID through NRF2 activation to counteract the NLRP3 inflammasome." Antioxidants 11, no. 1 (2022): 124.
[77] Habtemariam, Solomon. "The therapeutic potential of rosemary (Rosmarinus officinalis) diterpenes for Alzheimer’s disease." Evidence‐based Complementary and Alternative Medicine 2016, no. 1 (2016): 2680409.
[78] Kosmopoulou, Danai, Maria-Parthena Lafara, Theodora Adamantidi, Anna Ofrydopoulou, Andreas M. Grabrucker, and Alexandros Tsoupras. "Neuroprotective Benefits of Rosmarinus officinalis and Its Bioactives against Alzheimer’s and Parkinson’s Diseases." Applied Sciences 14, no. 15 (2024): 6417.
[79] Satoh, Takumi, Dorit Trudler, Chang-Ki Oh, and Stuart A. Lipton. (2022): 124.
[80] Pengelly, Andrew, James Snow, Simon Y. Mills, Andrew Scholey, Keith Wesnes, and Leah Reeves Butler. "Short-term study on the effects of rosemary on cognitive function in an elderly population." Journal of medicinal food 15, no. 1 (2012): 10-17.
[81] Faridzadeh, Arezoo, Yasaman Salimi, Hamidreza Ghasemirad, Meraj Kargar, Ava Rashtchian, Golnaz Mahmoudvand, Mohammad Amin Karimi et al. "Neuroprotective potential of aromatic herbs: rosemary, sage, and lavender." Frontiers in Neuroscience 16 (2022): 909833.
[82] Dabaghzadeh, Fatemeh, Mitra Mehrabani, Homa Abdollahi, and Somayyeh Karami-Mohajeri. "Antioxidant and anticholinesterase effects of rosemary (Salvia rosmarinus) extract: A double-blind randomized controlled trial." Advances in Integrative Medicine 9, no. 1 (2022): 69-74.
[83] Alvi, Sahir Sultan, Parvej Ahmad, Maleeha Ishrat, Danish Iqbal, and M. Salman Khan. "Secondary metabolites from rosemary (Rosmarinus officinalis L.): Structure, biochemistry and therapeutic implications against neurodegenerative diseases." Natural Bio-Active Compounds: Volume 2: Chemistry, Pharmacology and Health Care Practices (2019): 1-24.
[84] Perry, N. S. L., R. Menzies, F. Hodgson, P. Wedgewood, M-JR Howes, H. J. Brooker, K. A. Wesnes, and E. K. Perry. "A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age." Phytomedicine39 (2018): 42-48.
[85] Quirarte Báez, Sol María, Ana Lourdes Zamora Perez, Claudia Araceli Reyes Estrada, Rosalinda Gutiérrez Hernández, Martha Sosa Macías, Carlos Galaviz Hernández, Gloria Guillermina Guerrero Manriquez, and Blanca Patricia Lazaldo Ramos. "A shortened treatment with rosemary tea (Rosmarinus officinalis) instead of glucose in patients with diabetes mellitus type 2 (TSD)." https://doi. org/10.15586/jptcp. 
v26i4. 634 (2019).
[86] Bakirel, Tülay et al. “In vivo assessment of antidiabetic and antioxidant activities of rosemary (Rosmarinus officinalis) in alloxan-diabetic rabbits.” Journal of ethnopharmacology vol. 116,1 (2008): 64-73. 
[87] Tu, Zheng et al. “Rosemary (Rosmarinus officinalis L.) extract regulates glucose and lipid metabolism by activating AMPK and PPAR pathways in HepG2 cells.” Journal of agricultural and food chemistry vol. 61,11 (2013): 2803-10. 
[88] Rahimifard, Mahban et al. “Improvement in The Function of Isolated Rat Pancreatic Islets through Reduction of Oxidative Stress Using Traditional Iranian Medicine.” Cell journal vol. 16,2 (2014): 147-163.
[89] Begum, Asia et al. (2013): 61-73.
[90] al-Sereiti, M R et al. (1999): 124-30.
[91] Ulbricht, Catherine et al., (2010): 351-413. 
[92] Begum, Asia et al. (2013): 61-73.
[93] al-Sereiti, M R et al. (1999): 124-30.
[94] Ulbricht, Catherine et al., (2010): 351-413. 
[95] Begum, Asia et al. (2013): 61-73.
[96] al-Sereiti, M R et al. (1999): 124-30.
[97] Ulbricht, Catherine et al., (2010): 351-413. 
[98] Habtemariam, Solomon. “The Therapeutic Potential of Rosemary (Rosmarinus officinalis) Diterpenes for Alzheimer's Disease.” Evidence-based complementary and alternative medicine: eCAM vol. 2016 (2016): 2680409.
[99] Del Campo, José, Marie-Josèphe Amiot, and Christophe Nguyen-The. "Antimicrobial effect of rosemary extracts." Journal of food protection 63, no. 10 (2000): 1359-1368.
[100] Wang, Wei et al. “Antibacterial activity and anticancer activity of Rosmarinus officinalis L. essential oil compared to that of its main components.” Molecules (Basel, Switzerland) vol. 17,3 2704-13. 5 Mar. 2012.
[101] Food Standards Agency. Current EU approved additives and their E Numbers. Food Standards Agency (2016).
[102] Andrade, Joana M., Célia Faustino, Catarina Garcia, Diogo Ladeiras, Catarina P. Reis, and Patrícia Rijo. "Rosmarinus officinalis L.: an update review of its phytochemistry and biological activity." Future science OA 4, no. 4 (2018): FSO283.
[103] Somade, Oluwatobi T. "Camphor toxicity: A review of recent findings." Proceedings of the National Academy of Sciences, India Section B: Biological Sciences 93, no. 4 (2023): 775-790.